Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 14, 2331-2341
eCollection

The Difficulty Of Improving Quality Of Life In COPD Patients With Depression And Associated Factors

Affiliations

The Difficulty Of Improving Quality Of Life In COPD Patients With Depression And Associated Factors

Jeong Uk Lim et al. Int J Chron Obstruct Pulmon Dis.

Abstract

Objectives: Depression is a major comorbidity that affects clinical outcomes in patients with chronic obstructive pulmonary disease (COPD). COPD patients with depression are hospitalized more frequently, and show more acute exacerbations, decreased physical and social activities, and higher mortality compared to their non-depressed counterparts. In the present study, we investigated the clinical impact of depressive symptoms and associated clinical factors in Korean patients with COPD by evaluating multicenter cohort data.

Materials and methods: Patients with COPD enrolled in the Korean COPD Subtype Study, a multicenter observational study, from December 2011 to October 2014 were selected for evaluation. The initial evaluation of all patients included pulmonary function tests, 6 min walk distance (6MWD), the COPD Assessment Test (CAT), and the COPD-specific version of the St. George's Respiratory Questionnaire (SGRQ-C). Significant depression was defined as a Beck Depression Inventory-II (BDI-II) score ≥17.

Results: Among the 270 study patients, 19.6% had significant depression. The depressed group showed a higher proportion of females (41.4%), lower body mass index (BMI), and lower education level compared to the non-depressed group (p = 0.002, p = 0.008, and p = 0.019, respectively). The depressed group had significantly higher CAT and SGRQ-C scores, as well as a lower 6MWD, compared to the non-depressed group based on 6 month-interval serial measurements over 3 years. The total SGRQ-C score and the symptoms, activity, and impact domain scores were significant predictors of depression (area under curves [AUCs] of 0.699 [0.613-0.786], 0.670 [0.581-0.758], 0.680 [0.589-0.770], and 0.689 [0.603-0.776], respectively). From CAT score domains, sleep and energy scores were significant predictors of depression (AUCs of 0.619 [0.522-0.715] and 0.595 [0.504-0.685], respectively). SGRQ-C score, low BMI, and decreased 6MWD were significantly associated with depression in a multivariable analysis.

Conclusion: A considerable proportion of patients with COPD had depression, and a high SGRQ-C score, low BMI, and low 6MWD were significantly associated with depression. As improving quality of life in this subgroup is difficult, physicians should be more active in screening patients with significant depression.

Keywords: COPD Assessment Test; St. George’s Respiratory Questionnaire; association; depression.

Conflict of interest statement

Chin Kook Rhee has received consulting/lecture fees from MSD, AstraZeneca, GSK, Novartis, Takeda, Mundipharma, Boehringer-Ingelheim, Teva, and Bayer. The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Correlation analyses between the BDI-II score and (A) total SGRQ-C score, (B) the 6MWD, (C) the CAT, and (D) BMI. Abbreviations: BDI, Beck Depression Inventory; SGRQ-C, the COPD-specific version of the St George’s Respiratory Questionnaire; 6MWD, 6 min walk distance; CAT, COPD Assessment Test; BMI, body mass index.
Figure 2
Figure 2
Changes in (A) SGRQ-C score, (B) CAT score, (C) 6MWD, and (D) number of acute exacerbations/year by follow-up timepoint. Abbreviations: SGRQ-C, the COPD-specific version of the St George’s Respiratory Questionnaire; 6MWD, 6 min walk distance; CAT, COPD Assessment Test.

Similar articles

See all similar articles

References

    1. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP - DOI - PubMed
    1. Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest. 2000;117(2 Suppl):1s–4s. doi:10.1378/chest.117.2_suppl.1S - DOI - PubMed
    1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: global Burden of Disease Study. Lancet. 1997;349(9064):1498–1504. doi:10.1016/S0140-6736(96)07492-2 - DOI - PubMed
    1. Tsai TY, Livneh H, Lu MC, Tsai PY, Chen PC, Sung FC. Increased risk and related factors of depression among patients with COPD: a population-based cohort study. BMC Public Health. 2013;13:976. doi:10.1186/1471-2458-13-976 - DOI - PMC - PubMed
    1. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–555. doi:10.1164/rccm.200703-456SO - DOI - PubMed
Feedback